Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LECANEMAB-IRMB vs LENALIDOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LECANEMAB-IRMB vs LENALIDOMIDE: Safety Overview

Metric LECANEMAB-IRMB LENALIDOMIDE
Total FAERS Reports 2,469 349,955
Deaths Reported 82 35,942
Death Rate 3.3% 10.3%
Hospitalizations 474 86,495
Average Patient Age 74.1 yrs 69.9 yrs
% Female Patients 58.6% 50.0%
FDA Approval Date N/A Aug 3, 2023
Manufacturer Eisai Inc. Padagis US LLC
Route N/A ORAL
Marketing Status Prescription Prescription